BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18974552)

  • 21. Inflammatory myopathies and systemic disorders: a review of immunopathogenetic mechanisms and clinical features.
    Mantegazza R; Bernasconi P; Confalonieri P; Cornelio F
    J Neurol; 1997 May; 244(5):277-87. PubMed ID: 9178151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Limited effects of high-dose intravenous immunoglobulin (IVIG) treatment on molecular expression in muscle tissue of patients with inflammatory myopathies.
    Barbasso Helmers S; Dastmalchi M; Alexanderson H; Nennesmo I; Esbjörnsson M; Lindvall B; Lundberg IE
    Ann Rheum Dis; 2007 Oct; 66(10):1276-83. PubMed ID: 17277004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inflammatory myopathies: diagnosis and classifications].
    Dimitri D
    Presse Med; 2009; 38(7-8):1141-63. PubMed ID: 19282137
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathological diagnosis of specific inflammatory myopathies.
    Carpenter S; Karpati G
    Brain Pathol; 1992 Jan; 2(1):13-9. PubMed ID: 1341942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunolocalization of FAS and FAS ligand in inflammatory myopathies.
    De Bleecker JL; Meire VI; Van Walleghem IE; Groessens IM; Schröder JM
    Acta Neuropathol; 2001 Jun; 101(6):572-8. PubMed ID: 11515785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polymyositis: an overdiagnosed entity.
    van der Meulen MF; Bronner IM; Hoogendijk JE; Burger H; van Venrooij WJ; Voskuyl AE; Dinant HJ; Linssen WH; Wokke JH; de Visser M
    Neurology; 2003 Aug; 61(3):316-21. PubMed ID: 12913190
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification, diagnosis, and management of idiopathic inflammatory myopathies.
    Lazarou IN; Guerne PA
    J Rheumatol; 2013 May; 40(5):550-64. PubMed ID: 23504386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Idiopathic myositis].
    Burgunder JM
    Ther Umsch; 2003 Jul; 60(7):407-12. PubMed ID: 12956034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies.
    Dastmalchi M; Grundtman C; Alexanderson H; Mavragani CP; Einarsdottir H; Helmers SB; Elvin K; Crow MK; Nennesmo I; Lundberg IE
    Ann Rheum Dis; 2008 Dec; 67(12):1670-7. PubMed ID: 18272672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifactorial study of inflammatory myopathies. Report of 29 cases.
    Angelini C; Menegazzo E; Fanin M
    Ital J Neurol Sci; 1993 Jan; 14(1):69-76. PubMed ID: 8473155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inflammatory myopathies: clinical, diagnostic and therapeutic aspects.
    Mastaglia FL; Garlepp MJ; Phillips BA; Zilko PJ
    Muscle Nerve; 2003 Apr; 27(4):407-25. PubMed ID: 12661042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunopathogenesis of inflammatory myopathies.
    Dalakas MC
    Ann Neurol; 1995 May; 37 Suppl 1():S74-86. PubMed ID: 8968219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymyositis and dermatomyositis.
    Dalakas MC; Hohlfeld R
    Lancet; 2003 Sep; 362(9388):971-82. PubMed ID: 14511932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current therapy for polymyositis and dermatomyositis].
    Chérin P
    Rev Med Interne; 2008 Jun; 29 Spec No 2():9-14. PubMed ID: 18927983
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic advances and future prospects in immune-mediated inflammatory myopathies.
    Dalakas MC
    Ther Adv Neurol Disord; 2008 Nov; 1(3):157-66. PubMed ID: 21180574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of inflammatory myopathies.
    Mastaglia FL; Phillips BA; Zilko P
    Muscle Nerve; 1997 Jun; 20(6):651-64. PubMed ID: 9149071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Histological data in inflammatory myositis].
    Mikol J; Polivka M
    Ann Med Interne (Paris); 2001 Nov; 152(7):465-79. PubMed ID: 11965088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative morphometric study of muscle in inclusion body myositis.
    Verma A; Bradley WG; Soule NW; Pendlebury WW; Kelly J; Adelman LS; Chou SM; Karpati G; Brenner JF
    J Neurol Sci; 1992 Oct; 112(1-2):192-8. PubMed ID: 1335036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet-endothelial cell adhesion molecule-1 and CD146: soluble levels and in situ expression of cellular adhesion molecules implicated in the cohesion of endothelial cells in idiopathic inflammatory myopathies.
    Figarella-Branger D; Schleinitz N; Boutière-Albanèse B; Camoin L; Bardin N; Guis S; Pouget J; Cognet C; Pellissier JF; Dignat-George F
    J Rheumatol; 2006 Aug; 33(8):1623-30. PubMed ID: 16881117
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired immune and inflammatory myopathies: pathologic classification.
    Pestronk A
    Curr Opin Rheumatol; 2011 Nov; 23(6):595-604. PubMed ID: 21934500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.